Genetics Testing-Women's Health

Women's Health

With rapidly advancing research in molecular diagnostics, the strategy for detection and treatment of common women's health conditions is evolving.

Physicians and pathologists are turning more to molecular diagnostic testing to better provide early diagnosis of disease. These early diagnoses combined with advancements in treatment are leading to better clinical outcomes and healthier lives.

Advanta's women's health test offerings are tailored to meet the OB/GYN clinician's needs. Our women's health testing menu includes liquid based PAP screening combined with HPV testing which adheres to ASCCP and ACOG guidelines, sexual health infectious disease testing, vaginitis testing and prenatal carrier genetics. Our lab also offers surgical pathology as well as breast and urine cytology services. Our goal is to provide a comprehensive menu of services beneficial to the OB/GYN clinician with a single point of contact. This increases accuracy and turn-around time of results which leads to faster treatment, the correct treatment, and improved outcomes.

Women's Health Testing

CARRIER SCREENING Sample Type: x 1-4 mL EDTA purple top tube
ASSAY Description
Cystic Fibrosis
INFECTIOUS DISEASES
ASSAY Description
HPV-HR QUAD
Infectious agent detection by nucleic acid (DNA or RNA), papilomavirus, human; amplified probe technique
UroGen Plus QUAD
Infectious agent detection by nucleic acid (DNA or RNA), amplified probe technique
STD-6 QUAD
Infectious agent detection by nucleic acid (DNA or RNA), amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), Trichomonas (TV); amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), Chlamydia (CT); amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), Gonorrhea (NG); amplified probe technique
BV QUAD
Infectious agent detection by nucleic acid (DNA or RNA), amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), G. vaginalis (GV); amplified probe technique
Candida Plus QUAD
Infectious agent detection by nucleic acid (DNA or RNA), Candida spp.; amplified probe technique
Resolve QUAD
Infectious agent detection by nucleic acid (DNA or RNA), Candida spp.; amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), Trichomonas (TV); amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), Candida spp.; amplified probe technique
Infectious agent detection by nucleic acid (DNA or RNA), G. vaginalis (GV); amplified probe technique
LIQUID CYTOLOGY TESTING Sample Type: Test from a single liquid cytology specimen (ThinPrep® PAP solution) for:
ASSAY Description
Human papillomavirus (HPV)
14 types including HPV 16/18
Chlamydia trachomatis (CT)
Neisseria gonorrhoeae (NG)
Trichomonas vaginalis (TV)
WOMEN'S HEALTH Sample Type: Vaginal swabs
ASSAY Description
Atopobium vaginae
Bacteroides fragilis
Candida albicans
Candida dubliniensis
Candida glabrata
Candida krusei
Candida parapsilosis
Candida tropicalis
Chlamydia trachomatis
Gardnerella vaginalis
Mobiluncus curtisii
Mobiluncus mulieris
Mycoplasma genitalium
Mycoplasma hominis
Neisseria gonorrhoeae
Prevotella bivia
Trichomonas vaginalis
Ureaplasma parvum
Ureaplasma urealyticum

PAP with Age Based Screening Protocols:

Our PAP test menu is designed to help clinicians order appropriate testing based on ACOG Practice Guidelines for cervical cancer screening and Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) screening.

Patients aged 21-25 Patients will receive Sure Path
or Thin Prep Image-guided PAP
If the result of the PAP is ASC-US, a high-risk HPV
test will be performed. Additionally, testing for
CT/NG will be performed.
Patients aged 26-29

Patients will receive Sure Path
or Thin Prep Image-guided PAP

If the Pap result is ASC-US then the HPV assay
will be performed at an additional charge.
Patients aged 30-65

Patients will receive Sure Path
or Thin Prep Image-guided PAP
AND be co-tested for high risk HPV types

Our Providers Result Portal can be used to access patient reports. You can request access to your patient results through the Providers Results Portal by completing and submitting a Provider Registration form. Please include a secure email address for delivery of portal login and password. If you have already registered with Advanta Analytical Laboratories please contact us at the phone number below or email
register@aalabs.com so that we may assist you in gaining access to the Providers Results Portal.

Provider Registration

Advanta Customer Service

Phone: 903·707·2197
Fax: 903·839·2494